VOL 20 NO4 Oct-Dec 2013
Total Page:16
File Type:pdf, Size:1020Kb
VOL 20 NO 4 Oct - Dec 2013 ISSN 1727-2874 News & Short Communications Consultancy Services – A New and Little-Known Role of a Pharmacist An Overview of Contemporary Treatment for Rheumatoid Arthritis (2 CE Units) Over-the-Counter Options for Diarrhea in Children Distinction of the Bulbs of Fritillariae thunbergii Miq., Fritillariae ussuriensis Maxim and Fritillariae huperhensis Hsiao et K.C. Hsia by Concert Techniques Concert Approach to the Authentication, Qualitative Evaluation and Bioactivity Assessment of Beimu Invitation letter Hong Kong Pharmacy Conference 2014 The Annual General Meeting of the Pharmaceutical Society of Hong Kong and the 20th Anniversary of the Hong Kong Pharmaceutical Journal A weekend trip to Taipei with the President of PSHK ACTILYSE®/ENANTONE® 6 MONTH DPS 30MG Editorial An Opportunity to Turn the Tide – My Ponder After Eighteen Years of Association with HKPJ I am very pleased to present to will always be there. Fortunately, starting from last summer you the latest issue of Hong Kong we have and will continue to have more qualifi ed pharmacists Pharmaceutical Journal (HKPJ), graduating from both local pharmacy schools than ever before. which has a history of more than This means that the pharmacy community will have a steady twenty years by this month. From growth in term of number from now on. This phenomenon may the viewpoint of growth of a human gradually solve the problem as more number of registered being, it is regarded reaching a stage pharmacists making their endeavor. When both pharmacy of mature. I believe no one would schools grow and stabilized, academic staff in these two doubt that HKPJ is the only local schools should also spare some efforts and manpower to keep pharmaceutical journal as there is no this journal running. other similar one available in Hong Kong. Furthermore, HKPJ has been published so regular and Equally important is to promote the growth of this journal professional to cover some in-depth issues or studies relevant by increasing the number of readers. If more people read this to pharmacy practices since its’ birth in 1992. Except the fi rst journal, more feedback and contributions will be generated. two volumes, I have witnessed its growth and changes in the In the past, the distribution of our journal was basically last eighteen years; fi rst as an author in the fi rst two years and relied on mailing the hardcopy to our members, which is then became an editor for two sections and about fi ve years not only very costly but also has narrow circulation. Today, ago took over the task as the editor-in-chief of this journal. publishers of many journals, whether new or old, well known Throughout these twenty years although one or a few issues or unknown, have already switched to adopt online mode were occasionally missed or delayed, all together we have of circulation in addition to traditional mode of printing with published nearly 80 issues and three booklets on consolidated an aim to strengthen their infl uences and impacts as much list of the poisons, antibiotics and dangerous drugs so far. as possible to a larger population. Therefore, if HKPJ really Its existence and improvement each issue after issue is the wants to play an infl uential role in our society, we should proof of joint efforts between editors and authors. Without their change our mentality. Increase in number of readers is devotion, hard work and contribution, its publication was quite absolutely unavoidable and free accessible online is probably impossible. Hence, I have to give my gratitude to all our section the only way for reaching this goal. I sincere hope that with editors as they have been so cooperative. They have done the supports and involvements of some new bloods and also their part so well on voluntary basis and they have tried their the support from both pharmacy schools, we could turn this best to secure good articles for the section that they take care journal to a world class one and demonstrate to the world of of. By comparing the numbers of qualifi ed members to that of pharmaceutical fi eld that we, the Hongkonger, can do it. other healthcare professionals, pharmacy community is indeed the smallest professional body in Hong Kong. Yet we have the As I shall retire in about the next couple of years, it is most colorful journal. What more important is that we frequently really necessary to identify someone who has the same vision, have a good range of articles in each issue and we should sacrifi ce spirit and endurance to work day and night at the be proud of our achievement made by this small professional last minute for taking over my role as the editor-in-chief if we community. want this journal to be sustainable and popular. This is the opportunity for whoever wants to turn the tide. Having said that it doesn’t mean HKPJ is already good enough to meet the global standard of a professional journal. In this issue, we are lucky to have contributions from Indeed there are still plenty of room for us to improve and different authors. These articles cover the whole range of grow. For example, the quality of content and the originality different sections in our journal which has not been able to of each article are still far below international standard and meet for some time. At the moment when you receive this these are the areas required further enhancement. One of issue by post, I think it will be very close to Chinese Lunar New the major problems facing by every editor is the shortage of Year of the horse. Hence, I hope that you will enjoy reading this good article in hand. From the academic point of view, HKPJ issue at home during the spring holiday and of course, wish is the fl agship of the Hong Kong Pharmaceutical Society and you a prosperous and happy New Year ahead. every article present in this journal should be well written and should be present with high quality whether from educational or explorative point of view. But honestly speaking, our journal has its indigenous limitation at this moment as the number of Cheung Hon-Yeung active pharmacist in Hong Kong is small. Before it reaches to a Editor-in-Chief critical mass, the recurrent of inadequate submission of articles 15th January, 2014 HKPJ VOL 20 NO 4 Oct - Dec 2013 190 VOL 20 NO 4 Oct - Dec 2013 ISSN 1727-2874 Editorial EDEDITIORIALITIORIAL COCOMMITTEEMMITTEE CHEUNG, Hon-Yeung 190 Editor-in-ChiefEditor-in-Chief CHEUNG,CHEUNG, Hon-Yeung ManagingManaging Editors CHENG,CHENG, MaryMary News & Short Communications TSANG,TSANG, Warren Cardiovascular Outcomes for Saxagliptin Ruled Out? Not Quite Yet 193 SecretarySecretary WONG,WONG, JohnnyJohnny TreasurerTreasurer TAI, CCandyandy Use of Eprex® (epoetin alfa) in Chronic Kidney Disease Patients 193 Business ManagerManager KWAN,KWAN, WandaWanda KWOK,KWOK, Ritchie Contraindicated? Only in Subcutaneous, as experts say Section Editors PharmacyPharmacy Education & Practice CHONG,CHONG, DonaldDonald Fentanyl Increases Risk of Serotonin Syndrome when Co-administrated with 193 CHAN,CHAN, PhoebePhoebe Serotonergic Agents DrugsDrugs & Therapeutics CHAN,CHAN, EstherEsther LEUNG,LEUNG, WilsonWilson Australian Government Deregister Oral Ketoconazole 194 OTCOTC & Health EWIG,EWIG, CCelesteeleste Pharmaceutical Techniques & TechnologyTechnology CHEUNG,CHEUNG, HYHY The Benefi ts of Combined Hormonal Contraceptives Continue to 194 TTONG,ONG, HenrHenryy Outweigh Risks Herbal Medicines & Nutraceuticals CHEUNG,CHEUNG, HYHY SocietySociety Activities WONG,WONG, Helen Australian Warns Safety Concern for Mefl oquine Hydrochloride (Lariam) 194 NewNew ProductsProducts CHAN,CHAN, IvyIvy LEUNG,LEUNG, LucillaLucilla PANG,PANG, BobbyBobby Cinacalcet May Cause Arrhythmia, Warns the Canadian Government 195 EDITORIALEDITORIAL ADVISORY BOARDBOARD A Randomized Trial of Colchicine for Acute Pericarditis 195 Prof.Prof. CHAN,CHAN, Hak-Kim Prof.Prof. CHANG,CHANG, Pong Prof.Prof. CHERN,CHERN, Ji-Wang ProProf.f. CHIANG,CHIANG, CChiao-Hsihiao-Hsi The New Oral Anticoagulants: Post-marketing Increased Risk of Bleeding 195 Dr. CHING,CHING, Wei-Mei Prof.Prof. CHO,CHO, CChi-Hinhi-Hin Prof.Prof. CHOW,CHOW, SS MoseMosess Prof.Prof. HUI,HUI, SC SSaraharah FDA Warns Potiga (Ezogabine) May Link To Retinal Abnormalities And Blue 196 Prof.Prof. LI,LI, CCHH Paul Prof.Prof. LI,LI, Wan-Po Alain Skin Discoloration Prof.Prof. LEE, An-Rong Prof.Prof. LEE, Hon-leung VincentVincent Dr. MORGAN,MORGAN, Rae M. Prof.Prof. O’TOOLE,O’TOOLE, Desmond K Second Thought When Switching Anti-epileptic: MHRA Issues New Update 196 Dr. TIAN,TIAN, Hui Dr. WORSLEY,WORSLEY, Alan Prof.Prof. YANG,YANG, Chih-HsinChih-Hsin DaviDavidd Going Nuts? 196 The HongHong KongKong Pharmaceutical Journal, the publisher, the editorial board and the respective member societies are not responsible for the The “Come Back” of Rosiglitazone 197 completenesscompleteness and accuracyaccuracy ofof the articles and advertisements containedcontained in the HongHong KongKong Pharmaceutical Journal. The Journal will New Labelling Requirement of Proprietary Chinese Medicines containing 197 notnot be liable to anyany damagesdamages to persons and properties. Readers are Polygoni Multifl ori Radix (何首烏) advised to approach the respective authors and advertisers forfor informationinformation in case ofof doubts.doubts. CopyrightCopyright © 2013 bbyy HonHongg KonKongg Pharmaceutical Journal Pharmacy Education & Practice All rightsrights reserved. No part ofof this publication or its supplement maymay be Consultancy Services – A New and Little-Known Role of a Pharmacist 198 reproduced or transmitted in anyany formform or byby anyany means, electronic or CHENG, Kin Wa; CHONG, Donald Wing-kit mechanical, includingincluding photocopying,photocopying, recording,recording, or anyany informationinformation storagestorage and retrieval system,system, without permission in writingwriting fromfrom the Publisher. Drug & Therapeutics All communications and enquiriesenquiries should be directed to:to: An Overview of Contemporary Treatment for Rheumatoid Arthritis (2 CE Units) 200 The Secretary, Hong Kong Pharmaceutical Journal, CHEUNG, Suet-Ying Shirley; CHAU, Yin-Yan Ian; LAM, Chi-Kei Angel G.P.O.